Synergy Asset Management, LLC Neurocrine Biosciences Inc Transaction History
Synergy Asset Management, LLC
- $776 Million
- Q1 2025
A detailed history of Synergy Asset Management, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Synergy Asset Management, LLC holds 8,765 shares of NBIX stock, worth $1.09 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
8,765
Previous 7,222
21.37%
Holding current value
$1.09 Million
Previous $985,000
1.62%
% of portfolio
0.12%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding NBIX
# of Institutions
649Shares Held
97.1MCall Options Held
749KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.77 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.24 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$691 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$607 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$334 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.9B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...